These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13990064)

  • 21. [THE PSYCHOPHYSIOLOGICAL EFFECTS OF METHYLDOPA].
    SAINTJEAN A; DONALD MW; BAN TA
    Union Med Can; 1963 Dec; 92():1420-2. PubMed ID: 14101831
    [No Abstract]   [Full Text] [Related]  

  • 22. Agranulocytosis with alpha methyl DOPA.
    HALLWRIGHT GP
    N Z Med J; 1962 Sep; 61():470-2. PubMed ID: 13952193
    [No Abstract]   [Full Text] [Related]  

  • 23. Intraocular pressure studies with alpha-methyl-dopa.
    LAIBSON PR; KRISHNAN ; LEOPOLD IH
    Arch Ophthalmol; 1962 Nov; 68():648-50. PubMed ID: 13928121
    [No Abstract]   [Full Text] [Related]  

  • 24. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 25. Spontaneous formation of conjugates of alpha-methyl-DOPA and DOPA with serum proteins and experimental production of specific antibodies against these haptens.
    Cîrstea M; Suhaciu G; Cîrje M
    Physiologie; 1983; 20(1):3-10. PubMed ID: 6405406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog.
    STONE CA; ROSS CA; WENGER HC; LUDDEN CT; BLESSING JA; TOTARO JA; PORTER CC
    J Pharmacol Exp Ther; 1962 Apr; 136():80-8. PubMed ID: 13917453
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effects of reserpine, guanethidine and alpha-methyl-DOPA on resistance to cold].
    POULIOT M; LEBLANC J
    Arch Int Physiol Biochim; 1963 Jan; 71():73-82. PubMed ID: 13985777
    [No Abstract]   [Full Text] [Related]  

  • 28. Methyldopa in hypertension. Clinical and pharmacological studies.
    DOLLERY CT; HARINGTON M
    Lancet; 1962 Apr; 1(7233):759-63. PubMed ID: 13887051
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of alpha-methyl DOPA on the metabolism of 5-hydroxythryptamine in brain.
    ROOS BE; WERDINIUS B
    Life Sci (1962); 1963 Feb; 2():92-6. PubMed ID: 13974700
    [No Abstract]   [Full Text] [Related]  

  • 30. In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine.
    CARLSSON A; LINDQVIST M
    Acta Physiol Scand; 1962 Jan; 54():87-94. PubMed ID: 13876658
    [No Abstract]   [Full Text] [Related]  

  • 31. [THE MEDICAMENTOUS TREATMENT OF COMMON ARTERIAL HYPERTENSION].
    FRITEL D
    Rev Prat; 1963 Dec; 13():3999-4007. PubMed ID: 14100439
    [No Abstract]   [Full Text] [Related]  

  • 32. Methyldopa in the treatment of hypertension.
    BAYLISS RI; HARVEY-SMITH EA
    Lancet; 1962 Apr; 1(7233):763-8. PubMed ID: 13866047
    [No Abstract]   [Full Text] [Related]  

  • 33. A case of carcinoid syndrome, with an account of the use of alpha-methyl-dopa.
    NOBLE NR
    Med J Aust; 1961 Oct; 48(2)():589-92. PubMed ID: 14480157
    [No Abstract]   [Full Text] [Related]  

  • 34. [PHEOCHROMOCYTOMA AS A CAUSE OF CURABLE ARTERIAL HYPERTENSION. PRESENTATION OF A NEW CASE].
    RAPADOERRAZTI A; JIMENEZCASADO M; RODRIGUEZSANTOS A; NAVARRO V
    Rev Clin Esp; 1963 Aug; 90():247-51. PubMed ID: 14091050
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the therapeutic use of alpha-methyl-DOPA in the carcinoid syndrome].
    DUBACH UC; BLUMBERG A
    Klin Wochenschr; 1961 Sep; 39():973. PubMed ID: 13888006
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies of the modification of central effects of 3,4-dioxyphenyl-alanine (DOPA) by alpha-methyl-dioxyphenylalanine (alpha-methyl-DOPA)].
    Matthies H; Fähse C; Lietz W
    Acta Biol Med Ger; 1967; 19(4):529-34. PubMed ID: 5596674
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of alpha-methyl DOPA and some other decarboxylase inhibitors on brain 5-hydroxtryptamine.
    DRAIN DJ; HORLINGTON M; LAZARE R; POULTER GA
    Life Sci (1962); 1962 Mar; 1():93-7. PubMed ID: 13887715
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical trial of a new hypotensive drug, methyldopa ("aldomet").
    BAUMGARTEN A
    Med J Aust; 1962 Jul; 49(2)():52-5. PubMed ID: 13865946
    [No Abstract]   [Full Text] [Related]  

  • 39. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
    Rivera-Calimlim L
    Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ACTION OF ALPHA-METHYLDOPA (AMD) ON EMOTIONAL BEHAVIOR OBJECTIFIED BY "GROUP TOXICITY" PRODUCED BY DL-AMPHETAMINE AND DL-DIHYDROXYPHENYLALANINE IN MICE].
    HALPERN BN; DRUDI-BARACCO C; BESSIRARD D
    C R Seances Soc Biol Fil; 1963 Dec; 157():1421-6. PubMed ID: 14091868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.